158 related articles for article (PubMed ID: 30429571)
1. Lymphoma: 4 big questions.
Eisenstein M
Nature; 2018 Nov; 563(7731):S55. PubMed ID: 30429571
[No Abstract] [Full Text] [Related]
2. Solving lymphoma's stem-cell problem.
Arney K
Nature; 2018 Nov; 563(7731):S48-S49. PubMed ID: 30429564
[No Abstract] [Full Text] [Related]
3. Lymphoma.
Brody H
Nature; 2018 Nov; 563(7731):S37. PubMed ID: 30429563
[No Abstract] [Full Text] [Related]
4. Towards the better diagnosis of lymphoma.
Drew L
Nature; 2018 Nov; 563(7731):S38-S40. PubMed ID: 30429567
[No Abstract] [Full Text] [Related]
5. Cell therapy in transplantation: A comprehensive review of the current applications of cell therapy in transplant patients with the focus on Tregs, CAR Tregs, and Mesenchymal stem cells.
Mansourabadi AH; Mohamed Khosroshahi L; Noorbakhsh F; Amirzargar A
Int Immunopharmacol; 2021 Aug; 97():107669. PubMed ID: 33965760
[TBL] [Abstract][Full Text] [Related]
6. New trends in lymphoma management.
Fridman M; Ezdinli EZ
N Y State J Med; 1971 Nov; 71(22):2661-4. PubMed ID: 4940115
[No Abstract] [Full Text] [Related]
7. Chimeric Antigen Receptor T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia.
Tomuleasa C; Fuji S; Berce C; Onaciu A; Chira S; Petrushev B; Micu WT; Moisoiu V; Osan C; Constantinescu C; Pasca S; Jurj A; Pop L; Berindan-Neagoe I; Dima D; Kitano S
Front Immunol; 2018; 9():239. PubMed ID: 29515572
[TBL] [Abstract][Full Text] [Related]
8. Sequential loss of tumor surface antigens following chimeric antigen receptor T-cell therapies in diffuse large B-cell lymphoma.
Shalabi H; Kraft IL; Wang HW; Yuan CM; Yates B; Delbrook C; Zimbelman JD; Giller R; Stetler-Stevenson M; Jaffe ES; Lee DW; Shern JF; Fry TJ; Shah NN
Haematologica; 2018 May; 103(5):e215-e218. PubMed ID: 29419431
[No Abstract] [Full Text] [Related]
9. CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy.
Falini B; Pileri S; Pizzolo G; Dürkop H; Flenghi L; Stirpe F; Martelli MF; Stein H
Blood; 1995 Jan; 85(1):1-14. PubMed ID: 7803786
[No Abstract] [Full Text] [Related]
10. Chimeric antigen receptor T-cell therapy targeting CD30 in Hodgkin lymphoma.
Savoldo B
Clin Adv Hematol Oncol; 2021 Jan; 19(1):24-26. PubMed ID: 33493145
[No Abstract] [Full Text] [Related]
11. Stuttering as the first sign of CAR-T-cell-related encephalopathy syndrome (CRES).
Gonzalez Castro LN; Dietrich J; Forst DA
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1917-1918. PubMed ID: 30539279
[No Abstract] [Full Text] [Related]
12. Gray Zone Lymphoma: Current Diagnosis and Treatment Options.
Pilichowska M; Kritharis A; Evens AM
Hematol Oncol Clin North Am; 2016 Dec; 30(6):1251-1260. PubMed ID: 27888879
[TBL] [Abstract][Full Text] [Related]
13. [Research progress of CAR-T cell therapy for relapsed/refractory diffuse large B-cell lymphoma].
Yang JJ; Sang W; Xu KL
Zhonghua Nei Ke Za Zhi; 2019 Nov; 58(11):849-852. PubMed ID: 31665867
[TBL] [Abstract][Full Text] [Related]
14. Should the concern of myelodysplastic syndrome affect the decision of auto-SCT in lymphoma?
Keung YK; Levitan D; Zamkoff K; Hurd D
Bone Marrow Transplant; 2010 Feb; 45(2):407-8. PubMed ID: 19633689
[No Abstract] [Full Text] [Related]
15. Use of gallium-67 scanning in the management of lymphoma.
Bakshi S; Bender MA
J Surg Oncol; 1973 Jun; 5(6):539-49. PubMed ID: 4589651
[No Abstract] [Full Text] [Related]
16. Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation.
Di Ianni M; Falzetti F; Carotti A; Terenzi A; Del Papa B; Perruccio K; Ruggeri L; Sportoletti P; Rosati E; Marconi P; Falini B; Reisner Y; Velardi A; Aversa F; Martelli MF
Best Pract Res Clin Haematol; 2011 Sep; 24(3):459-66. PubMed ID: 21925099
[TBL] [Abstract][Full Text] [Related]
17. Nodular lymphocyte-predominant Hodgkin lymphoma and T cell histiocyte-rich large B cell lymphoma: diagnosis in two monozygotic twins.
Cano I; Lozano M; Rodríguez A; Mate A; Adrados M; López Mdel M; Carro R; Montes-Moreno S
Histopathology; 2010 Jul; 57(1):159-62. PubMed ID: 20653789
[No Abstract] [Full Text] [Related]
18. Checkpoint blockade in lymphoma.
Armand P
Hematology Am Soc Hematol Educ Program; 2015; 2015():69-73. PubMed ID: 26637703
[TBL] [Abstract][Full Text] [Related]
19. Early splenectomy in lymphoproliferative disorders.
Yam LT; Crosby WH
Arch Intern Med; 1974 Feb; 133(2):270-4. PubMed ID: 4591267
[No Abstract] [Full Text] [Related]
20. Bullous and Exanthematous Lesions Associated With Chimeric Antigen Receptor T-Cell Therapy in a Patient With Diffuse Large B-Cell Lymphoma.
Hu Y; Zheng W; Qiao J; Cui Q; Zhu Y; Chang AH; Huang H
JAMA Dermatol; 2020 Sep; 156(9):1026-1028. PubMed ID: 32432646
[No Abstract] [Full Text] [Related]
[Next] [New Search]
